Oxygen Biotherapeutics (NASDAQ:OXBT) is scaling back global sales and marketing plans for its only commercialized product to focus on just two U.S. states following the termination of agreements with distributors in Switzerland and Mexico. Instead of selling its skin-care product Dermacyte in select global markets, Oxygen said it will now focus on selling in North […]
Ischemic stroke is the target of a new partnership between Oxygen Biotherapeutics (NASDAQ:OXBT) and Aurum Biosciences that aims to develop a diagnostic and a treatment for the condition. The agreement will pair the companies’ respective technologies: Aurum’s magnetic resonance imaging (MRI) technology has the potential to map salvageable tissue in the brain after a stroke […]
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.
Oxygen Biotherapeutics (NASDAQ:OXBT) plans to raise up to $7.5 million through a private placement with two unnamed institutional investors, financing that will be directed to the company’s drug pipeline that includes a clinical stage compound for treating traumatic brain injury. Morrisville, North Carolina-based Oxygen focuses on therapies that enhance the delivery of oxygen to damaged […]
The shakeout at Oxygen Biotherapeutics (NASDAQ:OXBT) continues with two board members of the biotechnology company resigning in the wake of disclosures of alleged improprieties leading to the ouster of former CEO Chris Stern. Morrisville, North Carolina-based Oxygen said the resignations of Rene Eckert and J. Melville Engle were not the result of any disagreement with […]
An audit investigation into former Oxygen Biotherapeutics (NASDAQ:OXBT) CEO Chris Stern concluded that Stern lied about his academic background and engaged in undisclosed securities deals with a vendor that he later tried to cover up. The audit report outlining the findings was included in the company’s quarterly report. Stern’s position as chairman and CEO of […]
Oxygen Biotherapeutics (NASDAQ:OXBT) is searching for a new top executive after terminating CEO Chris Stern in connection with an audit investigation. Morrisville, North Carolina-based Oxygen Biotherapeutics disclosed Stern’s termination in a securities filing Wednesday after the markets closed. The filing stated that Stern was terminated “for cause” in connection with an audit committee investigation “concerning […]
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
North Carolina biopharmaceutical company Oxygen Biotherapeutics (NASDAQ:OXBT) is teaming with a Scotland company to see if their respective technologies can work together in improving how to see and intervene in a stroke. Morrisville, North Carolina-based Oxygen Biotherapeutics announced on Monday a letter of intent to conduct preclinical research with Aurum Biosciences, which is based in […]
North Carolina biotechnology firm Oxygen Biotherapeutics (NASDAQ:OXBT) is researching a treatment for traumatic brain injury, but the company is preparing to raise $4.6 million for work on its other lines of business. Oxygen Biotherapeutics, based in Morrsiville, North Carolina, said that it has entered into an agreement to sell securities in a private placement to […]
Oxygen Biotherapeutics (NASDAQ:OXBT) plans to expand its traumatic brain injury clinical trial to India and the drug development company is now looking for a pharmaceutical partner who could help take its experimental treatment through clinical trials. Morrisville, North Carolina-based Oxygen Biotherapeutics has been studying a treatment that enhances the delivery of oxygen to injured tissue, […]
Oxygen Biotherapeutics President and COO Richard Kiral is retiring today after more than a decade at the pharmaceutical development company. Kiral’s employment agreement with Oxygen Biotherapeutics (NASDAQ:OXBT) allows him to retire after reaching age 70, which occurred earlier this year. On March 28, the Morrisville, North Carolina-based company entered into a resignation of employment and […]
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
A wound treatment developed by Oxygen Biotherapeutics of Durham, North Carolina, is seen by the U.S. Department of Defense as having potential applications to injuries to soldiers in the field.